Power-Laws and the Use of Pluripotent Stem Cell Lines

Bernhard M. Schuldt, Anke Guhr, Michael Lenz, Sabine Kobold, Ben D. MacArthur, Andreas Schuppert, Peter Löser & Franz-Josef Müller
It is widely accepted that the (now reversed) Bush administration’s decision to restrict federal funding for human embryonic stem cell (hESC) research to a few “eligible” hESC lines is responsible for the sustained preferential use of a small subset of hESC lines (principally the H1 and H9 lines) in basic and preclinical research. Yet, international hESC usage patterns, in both permissive and restrictive political environments, do not correlate with a specific type of stem cell...
This data repository is not currently reporting usage information. For information on how your repository can submit usage information, please see our documentation.